Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001140361-16-089151
Filing Date
2016-12-09
Accepted
2016-12-08 19:09:07
Documents
1
Effectiveness Date
2016-12-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 12522
  Complete submission text file 0001140361-16-089151.txt   13666
Mailing Address 3525 DEL MAR HEIGHTS ROAD, #821 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS ROAD, #821 SAN DIEGO CA 92130 (619) 987-7768
Oncternal Therapeutics, Inc. (Filer) CIK: 0001600987 (see all company filings)

EIN.: 464137807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-245323 | Film No.: 162042559